News BioBuzz January 2015 Wednesday January 28, 2015 from 5:00 PM to 7:00 PM EST Join the BioBuzz networking…Super UserJanuary 12, 2015
News Johns Hopkins looks for alternative funding for research as NIH grants lag – Baltimore Business Journal Johns Hopkins University President Ronald J. Daniels is scrambling to track down funding for young…Super UserJanuary 9, 2015
News How 23andMe Cashes In on Consumers’ Genes – MIT Technology Review Facebook generates about $8 a year in revenue from each of its users. But what…Super UserJanuary 9, 2015
News Different Research Papers Score Big with Scientists and the Public – Scientific American Hundreds of research papers are published every day worldwide. But which articles are most discussed…Super UserJanuary 9, 2015
News Hogan appoints Evergreen Advisors chair Mike Gill as DBED chief – Baltimore Business Journal R. Mike Gill, chairman of Columbia investment banking firm Evergreen Advisors, will become the next…Super UserJanuary 8, 2015
News New $75M investment fund created to back health companies A new $75 million investment fund has been created by Connecticut-based HealthInvest Equity Partners, according…Super UserJanuary 8, 2015
News PE HUB » Blend Therapeutics scores $21 mln Blend Therapeutics, Inc., a biopharmaceutical company discovering new classes of medicines to treat cancer, announced…Super UserJanuary 8, 2015
News EAGB Releases 2014 Regional Report The EAGB put together a year-end report on the regional economy for the second year,…Super UserJanuary 8, 2015
News Research Commercialization: How Much Control Should Universities Have? | Lab Manager According to a recent article in The National Law Review, universities controlling and supporting the…Super UserJanuary 8, 2015
News Leading Life Science Syndicate Commits $25 Million to Series A Funding to Launch Vtesse, Inc., the First Rare Disease Company Spun Out of Cydan Development, Inc. Vtesse, Inc., a rare disease company focused on developing drugs for Niemann-Pick Disease Type C…Super UserJanuary 7, 2015